<DOC>
	<DOCNO>NCT00842426</DOCNO>
	<brief_summary>The purpose E-LITE Study evaluate feasibility potential effectiveness two lifestyle intervention community base primary care set . The study aim assess change diet , exercise , behavioral self-management affect weight relate risk factor adults risk diabetes cardiovascular disease .</brief_summary>
	<brief_title>Evaluation Lifestyle Interventions Treat Elevated Cardiometabolic Risk Primary Care</brief_title>
	<detailed_description>In United States , epidemic obesity , result , epidemic diabetes . Obese individual pre-diabetes ( define impair fast glucose impair glucose tolerance ) high risk progression diabetes . A vast majority individual also increase risk cardiovascular disease concomitant risk factor , abdominal obesity , dyslipidemia , elevate blood pressure . Intensive lifestyle intervention focus dietary change , physical activity , behavior modification demonstrate efficacy achieve maintain clinically significant ( &gt; 5 % ) weight loss population patient pre-diabetes . However , effectiveness , cost-effectiveness , generalizability , sustainability intervention routine primary care setting remain unknown , rigorous clinical research need . The primary hypothesis E-LITE Study CM intervention reduce BMI SM intervention , turn reduce BMI usual care , 15 month . Secondarily , hypothesize , compare usual care , intervention participant associate great improvement waist circumference , lipid , blood pressure , blood glucose , lifestyle behavior , psychosocial well-being . In addition , examine durability weight loss behavioral change month initial 3-month intensive stage .</detailed_description>
	<mesh_term>Obesity</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<mesh_term>Prediabetic State</mesh_term>
	<mesh_term>Glucose Intolerance</mesh_term>
	<criteria>Ethnicity : All ethnic group ; Body mass index 25.039.9 kg/m2 ; Fasting plasma glucose 100 125 mg/dL ; Any two following : Waist circumference &gt; 40 inch men , &gt; 35 inch woman ( Asian American ≥ 35 inch men ; ≥31 inch woman ) ; Triglycerides &gt; 150 mg/dL ; Highdensity lipoprotein cholesterol ( HDLC ) &lt; 40 mg/dL men , &lt; 50 mg/dL woman ; Systolic blood pressure &gt; 130 mm Hg diastolic blood pressure &gt; 85 mm Hg . Having primary care physician ( PCP ) PAMF Los Altos Center ; Seen primary specialty care Palo Alto Region least precede 24 month ; A PAMF patient ≥ 12 month ; Able willing enroll meet requirement study . Inability speak , read understand English ; No regular access computer Internet email capability ; Triglycerides &gt; 400 mg/dL ; Systolic blood pressure &gt; 160 mm Hg diastolic blood pressure &gt; 100 mm Hg ; Initiation change drug therapy elevate blood pressure abnormal lipid level within past 3 month Having medical ( e.g. , celiac disease ) social condition ( e.g. , religious belief ) preclude dietary change ; Having medical physical condition make moderate intensity physical activity ( like brisk walk ) difficult unsafe ; Use weightloss medication past 3 month ; Regular use ( &gt; 5 days/month ) medication affect appetite weight ( e.g. , oral corticosteroid , insulin , certain oral hypoglycemics , certain antidepressant , etc . ) ; Currently enrol lifestyle intervention program PAMF elsewhere ; Planning undergo bariatric surgery study period ; Diagnosis Type 1 Type 2 diabetes mellitus ; Significant medical comorbidities , include uncontrolled metabolic disorder ( e.g. , thyroid , renal , liver ) , heart disease , stroke , ongoing substance abuse ; Renal insufficiency ( i.e. , GFR &lt; 60 mL/min/1.73m2 ) Diagnosis psychiatric disorder would limit adequate inform consent ability comply study protocol ; Diagnosis cancer ( nonmelanoma skin cancer ) active treat radiation chemotherapy within past 2 year ; Diagnosis terminal illness and/or hospice care ; Pregnant , lactate plan become pregnant study period ; Already enrol plan enroll research study would limit full participation study confound observation interpretation study 's finding ; Family/household member another study participant study staff member ; No long PAMF patient planning transfer care outside PAMF study period ; Planning move area study period ; PCP determination study inappropriate unsafe patient ; Investigator discretion clinical safety protocol adherence reason .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>Diabetes</keyword>
	<keyword>Cardiovascular disease</keyword>
	<keyword>Metabolic syndrome</keyword>
	<keyword>Cardiometabolic</keyword>
</DOC>